Page 39 - TD-1-1
P. 39
Tumor Discovery The mechanism of cancer-related cognitive decline
Neurocognitive decline following radiotherapy: Mechanisms https://doi.org/10.1007/s00018-019-03428-3
and therapeutic implications. Cancers (Basel), 12: 146.
84. Lanni C, Masi M, Racchi M, et al., 2021, Cancer and
https://doi.org/10.3390/cancers12010146 Alzheimer’s disease inverse relationship: an age-associated
79. McDowell LJ, Ringash J, Xu W, et al., 2019, A cross sectional diverging derailment of shared pathways. Mol Psychiatry,
study in cognitive and neurobehavioral impairment in long- 26(1): 280–295.
term nasopharyngeal cancer survivors treated with intensity- https://doi.org/10.1038/s41380-020-0760-2
modulated radiotherapy. Radiother Oncol, 131: 179–185.
85. Nebbioso A, Tambaro FP, Dell’Aversana C, et al., 2018,
https://doi.org/10.1016/j.radonc.2018.09.012
Cancer epigenetics: moving forward. PLoS Genet, 14(6):
80. Haldbo-Classen L, Amidi A, Lukacova S, et al., 2020, e1007362.
Cognitive impairment following radiation to hippocampus https://doi.org/10.1371/journal.pgen.1007362
and other brain structures in adults with primary brain
tumours. Radiother Oncol, 148: 1–7. 86. Rebeck GW, 2017, The role of APOE on lipid homeostasis
https://doi.org/10.1016/j.radonc.2020.03.023 and inflammation in normal brains. J Lipid Res, 58(8):
1493–1499.
81. Makale MT, McDonald CR, Hattangadi-Gluth JA, et al.,
2017, Mechanisms of radiotherapy-associated cognitive https://doi.org/10.1194/jlr.R075408
disability in patients with brain tumours. Nat Rev Neurol, 87. Ahles TA, Saykin AJ, Noll WW, et al., 2003, The
13(1): 52–64. relationship of APOE genotype to neuropsychological
https://doi.org/10.1038/nrneurol.2016.185 performance in long-term cancer survivors treated with
82. McHugh D, Gil J, 2018, Senescence and aging: causes, standard dose chemotherapy. Psychooncology, 12(6): 612–
consequences, and therapeutic avenues. J Cell Biol, 217(1): 619.
65–77. https://doi.org/10.1002/pon.742
https://doi.org/10.1083/jcb.201708092 88. Fernandez HR, Varma A, Flowers SA, et al., 2020, Cancer
83. Seo J, Park M, 2020, Molecular crosstalk between cancer chemotherapy related cognitive impairment and the impact
and neurodegenerative diseases. Cell Mol Life Sci, 77(14): of the Alzheimer’s disease risk factor APOE. Cancers (Basel),
2659–2680. 12: 3842.
https://doi.org/10.3390/cancers12123842
Volume 1 Issue 1 (2022) 11 https://doi.org/10.36922/td.v1i1.46

